A dynamic cross-section of business, clinical and biotechnical expertise with a proven track record of providing rapid access to breakthrough therapeutics.
Under the leadership of our President and Chief Executive Officer Alexander Hardy, BioMarin’s executive management team includes accomplished leaders with deep and broad executive experience. Supported by a staff of approximately 3,000 employees worldwide, we are focused on delivering first-in-class and best-in-class therapeutics to patients with rare genetic diseases.
Diversity, Equity & Inclusion
We value diverse perspectives from a broad spectrum of backgrounds, education, personalities, skill sets, experiences, and knowledge.Learn More about Diversity, Equity & Inclusion at BioMarin ⌃
Our purpose is the patient. Our passion is the science.Learn More about BioMarin ⌃